The European vascular access device market is well-established and will grow marginally over the forecast period. Unit sales will be supported by steady growth in the underlying patient population…
The Asia Pacific TEO device market will see moderate growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data, increasing access to the TEO…
The global laparoscopic surgical robotic device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term,…
Driven by the increasing prevalence of kidney conditions in this region, the market for Japanese urological devices will continue to expand through 2032, despite the negative impact of the COVID-19…
Aesthetic energy-based device procedure volumes will be supported by an expanded patient pool for these treatments, as well as product innovations and improvements that expand the indications and…
The COVID-19 pandemic has had a negative impact on the growth of the European diabetes care device market in the short term. However, the market is projected to be driven by the introduction of new…
Growth in the US market for gynecological devices will be driven by various factors including the aging female population (and corresponding increase in treatments for incontinence and AUB),…
The European laparoscopic device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent…
The European biopsy device market was negatively impacted by the COVID-19 pandemic. However, overall biopsy procedure volumes will continue to grow marginally through 2032, driven by rise in cancer…
The Asia Pacific gynecological device market will witness modest growth over the forecast period. This growth will primarily be driven by public and private efforts to increase awareness about…
The European PV device market will grow modestly over the forecast period, driven by increasing adoption of drug-eluting products as more clinical evidence for these technologies emerges, rising…
The US heart valve device market will continue to experience rapid growth, largely driven by the adoption of THV devices. Clinical investigations continue to generate positive results and propel…
The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs. However…
The Japanese PV device market will continue to experience modest growth through 2032 primarily due to growth in the endovascular procedure volumes along with the rising adoption of premium-priced…
The European PV device will grow modestly through 2032. Market expansion will be driven by an increasing PAD patient pool, adoption of drug-eluting technologies, and a rising preference for the…